Ulcerative colitis (moderate to severely active) - vedolizumab [ID691]: final appraisal determination document
![Ulcerative colitis (moderate to severely active) - vedolizumab [ID691]: final appraisal determination document](/proxy/?sourceUrl=http%3a%2f%2fwww.nice.org.uk%2fimages%2ficons%2fpdf.gif)
|
Ulcerative colitis (moderate to severely active) - vedolizumab [ID691]: final appraisal determination document
13 March 2015 (452.44 Kb 11 sec) |
This page was last updated: 11 March 2015